Compass Therapeutics, Inc. insider trading
Every open-market purchase and sale by Compass Therapeutics, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $96,850 4 trades by 2 insiders
3 months later: median +16.2% (+13.4% vs S&P 500) Insider sales, 5 years $0 0 trades by 0 insiders
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Compass Therapeutics, Inc.’s insiders pay?
From June 23, 2020 to October 2, 2026, 11 insiders reported 38 open-market purchases and 4 sales not made under a pre-set plan in Compass Therapeutics, Inc.
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 23 | — | — | 0 | — | May 27, 2025 |
| Gordon Carl L | Director | 5 | — | — | 1 | — | April 11, 2025 |
| Orbimed Advisors LLC | Director | 3 | — | — | 0 | — | November 10, 2022 |
| Bisker-Leib Vered | Chief Operating Officer | 0 | — | — | 2 | — | November 25, 2022 |
| Lerner Neil | Chief Accounting Officer | 2 | — | — | 0 | — | October 2, 2026 |
| Anderman Jonathan | Gen Counsel & Corporate Sec | 1 | — | — | 0 | — | April 8, 2025 |
| Ferneau Philip | Director | 1 | — | — | 0 | — | June 23, 2020 |
| Orbimed Capital Gp V LLC | Director | 1 | — | — | 0 | — | May 10, 2022 |
| Orbimed Capital Gp VI LLC | Director | 0 | — | — | 1 | — | April 11, 2025 |
| Orbimed Genesis Gp LLC | Director | 1 | — | — | 0 | — | November 8, 2021 |
| Sunderland Julie | Director | 1 | — | — | 0 | — | June 23, 2020 |